Optimizing Treatment for CTD-ILD - Takeaways - MDSpire

Optimizing Treatment for CTD-ILD

When autoimmune or connective tissue diseases cause inflammation or scarring of the lungs, both diagnosis and effective management can be challenging.

  • August 8, 2023

  • 5 min

Share

  • 1

    CTD-ILD is a challenging condition requiring coordinated care from pulmonologists, rheumatologists, and other specialists.

  • 2

    Temple's CTD-ILD program emphasizes a multidisciplinary approach to improve diagnosis, treatment planning, and patient experience.

  • 3

    Advanced treatment options for CTD-ILD include immunosuppressive medications, anti-fibrotic agents, and potential eligibility for clinical trials.

  • 4

    Timely referral for patients with connective tissue disease and ILD is crucial to limit disease progression and prevent irreversible lung damage.

  • 5

    The Temple Lung Center offers comprehensive services, including lung transplantation, and maintains communication with referring physicians.

Original Source(s)

Optimizing Treatment for CTD-ILD

  • August 8, 2023

Related Content

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.